Ian Kimber
Research Subjects
Ian Kimber has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Rebecca J. Dearman
Faculty of Life Sciences; University of Manchester; Manchester U.K.
14 shared publications David A. Basketter
4 shared publications- Marie Cumberbatch
Zeneca Central Toxicology Laboratory
4 shared publications D A Basketter
3 shared publicationsD. A. Basketter
SEAC Toxicology Unit Unilever Research Colworth MK44 1LQ Beds United Kingdom
3 shared publicationsLinda J. Lea
3 shared publications
Latest Publications
- 1 September 2016
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 136 (9) , S212
299 Fibroblasts from aged human skin show an augmented pro-inflammatory response to TLR4 stimulation compared to young fibroblasts
- 1 September 2016
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 136 (9) , S212
299 Fibroblasts from aged human skin show an augmented pro-inflammatory response to TLR4 stimulation compared to young fibroblasts
- 1 September 2016
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 136 (9) , S217
331 Addition of interleukin-17 alters the healthy keratinocyte secretome and causes inhibition of Langerhans’ cell migration
- 1 September 2016
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 136 (9) , S217
331 Addition of interleukin-17 alters the healthy keratinocyte secretome and causes inhibition of Langerhans’ cell migration
- 23 August 2013
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 170 (1) , 45-51
The hapten-atopy hypothesis III: the potential role of airborne chemicals
One explanation for the large increase in the prevalence of atopic disease in developed countries during the last 50 years is the ‘hygiene hypothesis’. This proposes that a reduced exposure to pathogenic microorganisms at a key period(s) during development results in the maintenance or acquisition of an atopic phenotype. Alternatively, or additionally, we have postulated that increased exposure to chemicals generally, and to irritant/haptenic chemicals in particular, during critical windows of maternal pregnancy/early life have also contributed to changes in the prevalence of atopic disease. Having previously reviewed the potential roles of oral and cutaneous exposure to chemicals on the subsequent diagnosis of atopic disease, we here consider possible evidence of a role for exposure to airborne chemicals as a contributory factor in acquired susceptibility to atopic allergy. After controlling for known confounders, five specific maternal occupations during pregnancy have been implicated as being associated with subsequent atopic disease in the offspring. Each of these occupations is characterized by high and persistent exposure to airborne chemicals. High‐level exposure to volatile organic compounds in the domestic environment, either during pregnancy or in early life, is also associated with development of childhood atopic disease. Similarly, sustained exposure to airborne chlorinated chemicals from swimming pools during childhood has been associated with the development of atopic allergy. A possible immunological basis for these associations is that exposure to certain airborne chemicals, even at low levels, can result in the delivery of ‘danger’ signals that, in turn, bias the immune response towards the selective induction or maintenance of preferential T helper 2‐type immune responses consistent with the acquisition of allergic sensitization.
- 23 August 2013
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 170 (1) , 45-51
The hapten-atopy hypothesis III: the potential role of airborne chemicals
One explanation for the large increase in the prevalence of atopic disease in developed countries during the last 50 years is the ‘hygiene hypothesis’. This proposes that a reduced exposure to pathogenic microorganisms at a key period(s) during development results in the maintenance or acquisition of an atopic phenotype. Alternatively, or additionally, we have postulated that increased exposure to chemicals generally, and to irritant/haptenic chemicals in particular, during critical windows of maternal pregnancy/early life have also contributed to changes in the prevalence of atopic disease. Having previously reviewed the potential roles of oral and cutaneous exposure to chemicals on the subsequent diagnosis of atopic disease, we here consider possible evidence of a role for exposure to airborne chemicals as a contributory factor in acquired susceptibility to atopic allergy. After controlling for known confounders, five specific maternal occupations during pregnancy have been implicated as being associated with subsequent atopic disease in the offspring. Each of these occupations is characterized by high and persistent exposure to airborne chemicals. High‐level exposure to volatile organic compounds in the domestic environment, either during pregnancy or in early life, is also associated with development of childhood atopic disease. Similarly, sustained exposure to airborne chlorinated chemicals from swimming pools during childhood has been associated with the development of atopic allergy. A possible immunological basis for these associations is that exposure to certain airborne chemicals, even at low levels, can result in the delivery of ‘danger’ signals that, in turn, bias the immune response towards the selective induction or maintenance of preferential T helper 2‐type immune responses consistent with the acquisition of allergic sensitization.
- 1 March 2004
- Published by Wiley in Contact Dermatitis
- Vol. 50 (3) , 208
P79 A chemical dataset for evaluation of alternative approaches to skin sensitization testing
- 1 March 2004
- Published by Wiley in Contact Dermatitis
- Vol. 50 (3) , 208
P79 A chemical dataset for evaluation of alternative approaches to skin sensitization testing
- 1 March 2004
- Published by Wiley in Contact Dermatitis
- Vol. 50 (3) , 206
P74 Categorisation of human sensitisation potency using local lymph node assay EC3 values
- 1 March 2004
- Published by Wiley in Contact Dermatitis
- Vol. 50 (3) , 206
P74 Categorisation of human sensitisation potency using local lymph node assay EC3 values
- 1 December 2002
- Published by Wiley in British Journal of Dermatology
- Vol. 147 (6) , 1278
Enumeration of the frequency of Langerhans cells in epidermis: reply from authors
- 1 December 2002
- Published by Wiley in British Journal of Dermatology
- Vol. 147 (6) , 1278
Enumeration of the frequency of Langerhans cells in epidermis: reply from authors
- Open Access
- 1 February 2001
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 59 (2) , 198-208
Skin Sensitization Testing in Potency and Risk Assessment
The purpose of this article is to review, and make recommendations for, the use of relevant skin sensitization test methods, for the purposes of determination of relative potency and the threshold dose necessary for the induction of skin sensitization, and for risk assessment. In addressing the first area, the utility of three guinea pig tests (the guinea pig maximization test, the occluded patch test, and the open epicutaneous test) of the local lymph node assay (LLNA) and of human volunteer testing for the assessment of relative potency and identification of thresholds for sensitization were considered. The following conclusions were drawn. (1) Although attempts have been made to modify the guinea pig maximization test for the purposes of deriving dose-response relationships, this method is usually unsuitable for determination of relative sensitizing potency. (2) Guinea pig methods that do not require the use of adjuvant and which employ a relevant route of exposure (the occluded patch test and the open epicutaneous test) are more appropriate for the assessment of relative skin-sensitizing potency. (3) The LLNA is suitable for the determination of relative skin sensitizing potency, and the adaptation of this method for derivation of comparative criteria such as EC3 values (the estimated concentration of test chemical required to induce a stimulation index of 3 in the LLNA) provides an effective and quantitative basis for such measurements. (4) For all the methods identified above, potency is assessed relative to other chemical allergens of known skin sensitizing potential. The estimation of likely threshold concentrations is dependent upon the availability of suitable benchmark chemicals of known potency for human sensitization. (5) Human testing (and specifically, the Human Repeat Insult Patch Test) can provide information of value in confirming the absence of skin sensitizing activity of formulations and products under specific conditions of use and exposure. Based on the above, the following recommendations are made. (1) If results are already available from suitable guinea pig tests, then judicious interpretation of the data may provide information of value in assessing relative skin sensitizing potency. This option should be explored before other analyses are conducted. (2) The LLNA is the recommended method for new assessments of relative potency, and/or for the investigation of the influence of vehicle or formulation on skin sensitizing potency. (3) Whenever available, human skin sensitization data should be incorporated into an assessment of relative potency. With respect to risk assessment, the conclusion drawn is that all the available data on skin-sensitizing activity in animals and man should be integrated into the risk-assessment process. Appropriate interpretation of existing data from suitable guinea pig studies can provide valuable information with respect to potency, as the first step in the development of a risk assessment. However, for de novo investigations, the LLNA is the method favored for providing quantitative estimations of skin-sensitizing potency that are best suited to the risk assessment process. Finally, human testing is of value in the risk assessment process, but is performed only for the purposes of confirming product safety.
- 1 February 2001
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 59 (2) , 198-208
Open AccessSkin Sensitization Testing in Potency and Risk Assessment
The purpose of this article is to review, and make recommendations for, the use of relevant skin sensitization test methods, for the purposes of determination of relative potency and the threshold dose necessary for the induction of skin sensitization, and for risk assessment. In addressing the first area, the utility of three guinea pig tests (the guinea pig maximization test, the occluded patch test, and the open epicutaneous test) of the local lymph node assay (LLNA) and of human volunteer testing for the assessment of relative potency and identification of thresholds for sensitization were considered. The following conclusions were drawn. (1) Although attempts have been made to modify the guinea pig maximization test for the purposes of deriving dose-response relationships, this method is usually unsuitable for determination of relative sensitizing potency. (2) Guinea pig methods that do not require the use of adjuvant and which employ a relevant route of exposure (the occluded patch test and the open epicutaneous test) are more appropriate for the assessment of relative skin-sensitizing potency. (3) The LLNA is suitable for the determination of relative skin sensitizing potency, and the adaptation of this method for derivation of comparative criteria such as EC3 values (the estimated concentration of test chemical required to induce a stimulation index of 3 in the LLNA) provides an effective and quantitative basis for such measurements. (4) For all the methods identified above, potency is assessed relative to other chemical allergens of known skin sensitizing potential. The estimation of likely threshold concentrations is dependent upon the availability of suitable benchmark chemicals of known potency for human sensitization. (5) Human testing (and specifically, the Human Repeat Insult Patch Test) can provide information of value in confirming the absence of skin sensitizing activity of formulations and products under specific conditions of use and exposure. Based on the above, the following recommendations are made. (1) If results are already available from suitable guinea pig tests, then judicious interpretation of the data may provide information of value in assessing relative skin sensitizing potency. This option should be explored before other analyses are conducted. (2) The LLNA is the recommended method for new assessments of relative potency, and/or for the investigation of the influence of vehicle or formulation on skin sensitizing potency. (3) Whenever available, human skin sensitization data should be incorporated into an assessment of relative potency. With respect to risk assessment, the conclusion drawn is that all the available data on skin-sensitizing activity in animals and man should be integrated into the risk-assessment process. Appropriate interpretation of existing data from suitable guinea pig studies can provide valuable information with respect to potency, as the first step in the development of a risk assessment. However, for de novo investigations, the LLNA is the method favored for providing quantitative estimations of skin-sensitizing potency that are best suited to the risk assessment process. Finally, human testing is of value in the risk assessment process, but is performed only for the purposes of confirming product safety.
- 1 February 2001
- Vol. 56 (1) , 48-54
The bronchial epithelium in asthma--much more than a passive barrier.
The bronchial epithelium has a multifunctional role in the airway. It is actively engaged in communicating with cells of the immune and inflammatory systems, as well as secreting cytoprotective molecules and acting as a physical barrier between the internal and external milieu of the lungs. In asthma, the bronchial epithelium is often damaged, with shedding of the columnar cells into the airway lumen. This damage and ensuing repair responses are proposed to orchestrate airway remodelling via activation of myofibroblasts in the underlying lamina reticularis. This allows the two cell types to work as a trophic unit, propagating and amplifying the response at the cell surface into the submucosa. In addition to structural damage, the epithelium displays an "activated" phenotype evident by activation of transcription factors such as nuclear factor kappa B (NF kappa B), and expression of mediators which directly or indirectly lead to a chronic cycle of inflammation and injury. A diverse number of innocuous stimuli trigger asthma. It is likely that interactions between genetic and environmental factors converge on common intracellular signalling pathways that regulate epithelial stress and repair. Of particular relevance is the NF kappa B signalling pathway and the mitogen activated protein kinase pathways (MAPKs), of which the mitogen activated extracellular regulated kinases (ERKs), and the stress activated P38 and c-Jun NH2 terminal kinase (JNKs) are best known. This review aims to highlight the importance of these signalling pathways in coordinating the response to diverse stimuli at the surface of the bronchial epithelium which leads to development and maintenance of the asthmatic state.
- 1 February 2001
- Vol. 56 (1) , 48-54
The bronchial epithelium in asthma--much more than a passive barrier.
The bronchial epithelium has a multifunctional role in the airway. It is actively engaged in communicating with cells of the immune and inflammatory systems, as well as secreting cytoprotective molecules and acting as a physical barrier between the internal and external milieu of the lungs. In asthma, the bronchial epithelium is often damaged, with shedding of the columnar cells into the airway lumen. This damage and ensuing repair responses are proposed to orchestrate airway remodelling via activation of myofibroblasts in the underlying lamina reticularis. This allows the two cell types to work as a trophic unit, propagating and amplifying the response at the cell surface into the submucosa. In addition to structural damage, the epithelium displays an "activated" phenotype evident by activation of transcription factors such as nuclear factor kappa B (NF kappa B), and expression of mediators which directly or indirectly lead to a chronic cycle of inflammation and injury. A diverse number of innocuous stimuli trigger asthma. It is likely that interactions between genetic and environmental factors converge on common intracellular signalling pathways that regulate epithelial stress and repair. Of particular relevance is the NF kappa B signalling pathway and the mitogen activated protein kinase pathways (MAPKs), of which the mitogen activated extracellular regulated kinases (ERKs), and the stress activated P38 and c-Jun NH2 terminal kinase (JNKs) are best known. This review aims to highlight the importance of these signalling pathways in coordinating the response to diverse stimuli at the surface of the bronchial epithelium which leads to development and maintenance of the asthmatic state.
- 29 January 2001
- Published by Elsevier in Toxicology
- Vol. 158 (1-2) , 59-64
The local lymph node assay and potential application to the identification of drug allergens
- 29 January 2001
- Published by Elsevier in Toxicology
- Vol. 158 (1-2) , 59-64
The local lymph node assay and potential application to the identification of drug allergens
- 1 January 2001
- Vol. 4 (1) , 60-5
Prediction of drug allergenicity: possible use of the local lymph node assay.
The mouse local lymph node assay (LLNA) is currently used for the prospective identification of chemicals that have the potential to cause skin sensitization and allergic contact dermatitis. In this respect, the assay has been fully and formally evaluated and validated, and has been accepted recently as a stand-alone method for the identification of potential skin sensitizers. The assay involves topical application of test substance and the subsequent measurement of proliferative responses in the lymph nodes draining the site of exposure. The testing of new drug entities using a similar assay technique could offer a potential alternative for the identification of potential drug allergens. Currently, the popliteal lymph node assay (PLNA), or modifications of it, are used in research studies for the identification of drugs which have the potential to cause allergic or autoimmunogenic reactions. The PLNA involves subcutaneous application of test substance into the hind footpad, followed by the measurement of proliferative responses, or other parameters of immune activation, in the popliteal lymph nodes. However, these assays have not been validated systematically and the potential utility of a modified LLNA for use in the identification of such compounds is discussed.
- 1 January 2001
- Vol. 4 (1) , 60-5
Prediction of drug allergenicity: possible use of the local lymph node assay.
The mouse local lymph node assay (LLNA) is currently used for the prospective identification of chemicals that have the potential to cause skin sensitization and allergic contact dermatitis. In this respect, the assay has been fully and formally evaluated and validated, and has been accepted recently as a stand-alone method for the identification of potential skin sensitizers. The assay involves topical application of test substance and the subsequent measurement of proliferative responses in the lymph nodes draining the site of exposure. The testing of new drug entities using a similar assay technique could offer a potential alternative for the identification of potential drug allergens. Currently, the popliteal lymph node assay (PLNA), or modifications of it, are used in research studies for the identification of drugs which have the potential to cause allergic or autoimmunogenic reactions. The PLNA involves subcutaneous application of test substance into the hind footpad, followed by the measurement of proliferative responses, or other parameters of immune activation, in the popliteal lymph nodes. However, these assays have not been validated systematically and the potential utility of a modified LLNA for use in the identification of such compounds is discussed.